Loading…
22-Oxocholestane oximes as potential anti-inflammatory drug candidates
22-Oxocholestanes bearing the oxime functionality in the side chain have been synthesized from diosgenin and evaluated in vivo as anti-inflammatory agents in an acute inflammation mouse ear model, against the commercial glucocorticoid dexamethasone. The final compounds were all regioselectively obta...
Saved in:
Published in: | European journal of medicinal chemistry 2019-04, Vol.168, p.78-86 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 22-Oxocholestanes bearing the oxime functionality in the side chain have been synthesized from diosgenin and evaluated in vivo as anti-inflammatory agents in an acute inflammation mouse ear model, against the commercial glucocorticoid dexamethasone. The final compounds were all regioselectively obtained with an E configuration at the oxime double bond. The title compounds reduced ear-induced inflammation and edema. The most active oximes repressed the expression of proinflammatory genes TNF-α, COX-2, and IL-6; including macrophage migration inhibitory factor. Overall, our data suggest that 22-oxocholestane oximes exert a strong in vivo anti-inflammatory activity.
[Display omitted]
•22-oxocholestane oximes were synthesized from diosgenin.•Regioselectivity was found for E/Z but no for R/S configuration.•The new hydroxyimino steroids exert anti-inflammatory activity in vivo.•Oximes repressed the expression of proinflammatory genes (TNF-α, COX-2, IL-6).•The most active oximes downregulated MIF. |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2019.02.035 |